Search

everythinglearnresearchcommunity

for

Search:↓

Androgen receptor overexpression can increase prostate cancer cell growth even without hormones.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

Certain gene combinations may affect prostate cancer risk, and GSTP1 methylation is linked to tumor aggressiveness.

PCPA induces hypersexual behavior in male rats regardless of age or castration status.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

VPS13C variants are linked to more severe REM sleep disorder and faster progression to Parkinson's disease.

The patient with a misplaced pituitary gland and interrupted pituitary stalk is being treated with hormone replacement.

Prolactin may influence skin glands and could be a target for treating acne and skin aging.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

Lower SMAD2/3 activation predicts more severe skin cancer.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Family caregivers take longer to fall asleep and have more sleep disturbances, which may contribute to their health problems.

The revised BASP classification for hair loss is less accurate and harder to use but could still be a viable option.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

The patient responded well to treatment with no disease progression.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Evaluate prolactin levels with androgen and thyroid tests to rule out endocrine issues in patients with SAHA syndrome symptoms.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

PRP injections with tadalafil and stretching safely improved Peyronie's symptoms but didn't significantly change curvature long-term.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

Finasteride effectively slowed hair loss and promoted hair growth in Taiwanese men with AGA.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Accurate assessment of puberty using Tanner staging is crucial for identifying normal and abnormal development.

Childhood and adult height, and early immune-related hospitalizations increase testicular cancer risk, while baldness, larger families, and sports reduce it.

The enzyme PA-PLA1α is important for proper hair follicle development.

Early detection and multidisciplinary treatment are crucial for managing Papillon-Lefévre syndrome.